We performed a systematic review and meta-analysis of published randomized, controlled trials to assess the overall risk for severe proteinuria with bevacizumab.
我们对已发表的随机、对照试验进行一项系统性回顾和荟萃分析，以评估应用贝伐单抗治疗引起重症蛋白尿的整体风险。
We performed a systematic review and meta-analysis of published randomized, controlled trials to assess the overall risk for severe proteinuria with bevacizumab.
我们对已发表的随机、对照试验进行一项系统性回顾和荟萃分析，以评估应用贝伐单抗治疗引起重症蛋白尿的整体风险。
应用推荐